[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Pt 2):87-92. PMID: 23675606. Abstract CommentRecommendBookmarkWatch